BTLA and graft versus host disease: The association between BTLA and GVHD has been discussed in preclinical investigations and showed that, in the first days after HSCT, the anti‐BTLA antibody could control GVHD, maintain the GVL effect through deactivating donor T cells, and cause a relative increase in natural regulatory T cells.89